Search results
Results from the WOW.Com Content Network
HIV Medicine is a bimonthly peer-reviewed medical journal covering HIV/AIDS research. It was established in 1999 and is published by Wiley-Blackwell on behalf of the British HIV Association, of which it is the official journal. It is also the official journal of the European AIDS Clinical Society and the Australasian Society for HIV Medicine. [1]
Mount Sinai Journal of Medicine: Medicine: John Wiley & Sons: English: 1934–2012 Movement Disorders: Neurology: Wiley-Liss: English: 1986–present Myanmar Medical Journal: Medicine: Myanmar Medical Association: English: 1953–present Nano Biomedicine and Engineering: Medicine: Open-Access House of Science and Technology: English: 2009–present
HIV testing should be repeated four to six weeks and three months after exposure. [17] People may experience signs and symptoms of acute HIV infection, including fever, fatigue, myalgia, and skin rash, while taking PEP. CDC recommends seeking medical attention for evaluation if these signs and symptoms occur during or after the month of PEP.
Scanning electron micrograph of HIV-1, colored green, budding from a cultured lymphocyte Diagram of HIV. HIV/AIDS research includes all medical research that attempts to prevent, treat, or cure HIV/AIDS, as well as fundamental research about the nature of HIV as an infectious agent and AIDS as the disease caused by HIV.
Pre-exposure prophylaxis (PrEP), is the use of medications to prevent the spread of disease in people who have not yet been exposed to a disease-causing agent. Vaccination is the most commonly used form of pre-exposure prophylaxis; other forms of pre-exposure prophylaxis generally involve drug treatment, known as chemoprophylaxis.
Birx became the director of the United States Military HIV Research Program at the Walter Reed Army Institute of Research, a position she held for nine years, from 1996 to 2005. In that position, Birx led the HIV vaccine clinical trial of RV 144, the first supporting evidence of any vaccine being effective in lowering the risk of contracting ...
The guidelines use new criteria to consider starting HAART, as described below. However, there remain a range of views on this subject and the decision of whether to commence treatment ultimately rests with the patient and his or her doctor. [citation needed] The US DHHS guidelines (published April 8, 2015) state: [citation needed]
The ACIP was established in March 1964 by the US Surgeon General to assist in the prevention and control of communicable diseases, [2] it recommends licensed new vaccines to be incorporated into the routine immunization schedule, recommends vaccine formulations, and reviews older vaccines to consider revising its recommendations.